Scarica l'app Stockscreener
74.00
0.19%
0.32
Precedente Chiudi:
$73.68
Aprire:
$74.21
Volume 24 ore:
10,987
Relative Volume:
0.04
Capitalizzazione di mercato:
$1.37B
Reddito:
$1.77M
Utile/perdita netta:
$-123.74M
Rapporto P/E:
-24.42
EPS:
-3.03
Flusso di cassa netto:
$-95.21M
1 W Prestazione:
-3.98%
1M Prestazione:
+0.94%
6M Prestazione:
+64.89%
1 anno Prestazione:
+6,799%
Intervallo 1D:
$72.33
$74.21
Intervallo di 1 settimana:
$68.08
$77.00
Portata 52W:
$1.07
$86.93
Praxis Precision Medicines Inc Stock (PRAX) Company Profile
Nome
Praxis Precision Medicines Inc
Settore
Industria
Telefono
617-300-8460
Indirizzo
99 HIGH STREET, 30TH FLOOR, BOSTON
Confronta PRAX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
| PRAX | 73.71 | 1.37B | 1.77M | -123.74M | -95.21M | -3.03 |
| VRTX | 446.48 | 115.74B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 740.49 | 81.65B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 591.15 | 34.86B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 249.56 | 32.09B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 103.47 | 24.49B | 3.30B | -501.07M | 1.03B | 11.54 |
Praxis Precision Medicines Inc Stock (PRAX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-09-19 | Iniziato | Truist | Buy |
| 2022-06-06 | Downgrade | Wedbush | Outperform → Neutral |
| 2021-12-16 | Iniziato | H.C. Wainwright | Buy |
| 2021-08-26 | Iniziato | BofA Securities | Buy |
| 2021-04-26 | Iniziato | William Blair | Outperform |
| 2020-11-11 | Iniziato | Wedbush | Outperform |
| 2020-11-10 | Iniziato | Cowen | Outperform |
| 2020-11-10 | Iniziato | Evercore ISI | Outperform |
| 2020-11-10 | Iniziato | Piper Sandler | Overweight |
Mostra tutto
Praxis Precision Medicines Inc Borsa (PRAX) Ultime notizie
Why Praxis Precision Medicines Stock Is Trading Higher Tuesday - MSN
Praxis Precision Medicines (NASDAQ:PRAX) Shares Gap Down Following Insider Selling - MarketBeat
Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Shares Bought by CIBC Asset Management Inc - MarketBeat
Alex Nemiroff Sells 8,239 Shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Stock - MarketBeat
Insider Selling: Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Insider Sells 5,188 Shares of Stock - MarketBeat
(PRAX) Proactive Strategies - Stock Traders Daily
Praxis Precision Medicines principal accounting officer sells $424,318 in stock - Investing.com India
Praxis Precision Medicines principal accounting officer sells $424,318 in stock By Investing.com - Investing.com Australia
Praxis Precision Medicines' general counsel sells shares worth $660,827 - Investing.com
Praxis Precision Medicines (NASDAQ:PRAX) Trading Down 7.9%Should You Sell? - MarketBeat
Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Cormorant Asset Management's Strategic Acquisition in Praxis Pre - GuruFocus.com
Verition Fund Management LLC Adjusts Stake in Praxis Precision M - GuruFocus.com
Capital Research Global Investors Acquires New Stake in Praxis P - GuruFocus.com
Equities Analysts Offer Predictions for PRAX FY2024 Earnings - MarketBeat
FY2024 Earnings Estimate for PRAX Issued By HC Wainwright - MarketBeat
Praxis Precision Medicines Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
HC Wainwright Reiterates "Buy" Rating for Praxis Precision Medicines (NASDAQ:PRAX) - MarketBeat
Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Q3 2024 Earnings Call Transcript - Insider Monkey
Praxis Precision Medicines Inc (PRAX) Is Worth A Look Now, Despite -5.10% Loss From High - Stocks Register
Praxis Precision Medicines Inc (PRAX) Q3 2024 Earnings Call Highlights: Strong Cash Position ... - Yahoo Finance
Praxis Precision Medicines Inc (PRAX) Q3 2024 Earnings Call Highlights: Strong Cash Position ... By GuruFocus - Investing.com Canada
Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2024 Financial Results - citybiz
Praxis Precision Medicines Reports Q3 2024 Results and Progress - TipRanks
Praxis Precision Medicines, Inc. (PRAX) Reports Q3 Loss, Misses Revenue Estimates - MSN
Praxis Precision Medicines to Participate in Three Upcoming November Investor Conferences - GlobeNewswire
Praxis Precision Medicines to Present at Three Major Healthcare Conferences in November | PRAX Stock News - StockTitan
Praxis Precision Advances CNS Disorder Therapies - TipRanks
Q3 2024 Praxis Precision Medicines Inc Earnings Call Transcript - GuruFocus.com
Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2024 Financial - The Bakersfield Californian
How the (PRAX) price action is used to our Advantage - Stock Traders Daily
Vanguard Group Inc's Strategic Acquisition in Praxis Precision M - GuruFocus.com
Assenagon Asset Management S.A. Decreases Stock Holdings in Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - MarketBeat
Praxis Precision Medicines (PRAX) to Release Quarterly Earnings on Wednesday - MarketBeat
Praxis Precision Medicines to Announce Third Quarter 2024 - GlobeNewswire
Praxis Precision Medicines to Announce Third Quarter 2024 Financial Results and Host Conference Call on Wednesday, November 6, 2024 - The Manila Times
(PRAX) Trading Advice - Stock Traders Daily
Moody Aldrich Partners LLC Purchases 7,224 Shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - MarketBeat
We're Not Very Worried About Praxis Precision Medicines' (NASDAQ:PRAX) Cash Burn Rate - Yahoo Finance
Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Praxis Precision To Report Aria Study Data In June - RTTNews
Will Praxis Precision Hit The Targets? - RTTNews
Praxis Precision Medicines revises executive severance terms - Investing.com
Where are the Opportunities in (PRAX) - Stock Traders Daily
Praxis Precision Medicines revises executive severance terms By Investing.com - Investing.com Australia
Praxis Precision To Reveal Key Trial Data On Essential Tremors - RTTNews
Dimensional Fund Advisors LP Sells 8,152 Shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - MarketBeat
Praxis Precision shares get boost on DEE space acquisition interest - Investing.com India
Praxis Precision Medicines (NASDAQ:PRAX) Reaches New 52-Week HighHere's Why - MarketBeat
Praxis Precision shares get boost on DEE space acquisition interest By Investing.com - Investing.com South Africa
Praxis Precision Medicines Inc Azioni (PRAX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Praxis Precision Medicines Inc Azioni (PRAX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Nemiroff Alex | General Counsel and Secretary |
Nov 14 '24 |
Sale |
80.20 |
8,239 |
660,827 |
10,301 |
| Mastrocola Lauren | Principal Accounting Officer |
Nov 14 '24 |
Option Exercise |
56.94 |
4,374 |
249,056 |
10,801 |
| Mastrocola Lauren | Principal Accounting Officer |
Nov 14 '24 |
Sale |
81.78 |
5,188 |
424,318 |
5,613 |
0.42%
0.16%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):